Quantcast

Latest V. Craig Jordan Stories

2014-07-23 12:32:39

HOUSTON, July 23, 2014 /PRNewswire-USNewswire/ -- V. Craig Jordan, Ph.D., one of the world's preeminent breast cancer experts will join The University of Texas MD Anderson Cancer Center this fall. Jordan is considered the "Father of Tamoxifen," the groundbreaking therapeutic drug that has saved countless lives. http://photos.prnewswire.com/prnvar/20140723/129913 As a professor in Breast Medical Oncology and Molecular and Cellular Oncology, Jordan will focus on the new biology of...

2013-07-16 23:22:35

ASCO expert panel includes University of New England researcher Nananda Col, M.D., M.P.H. Biddeford, ME (PRWEB) July 16, 2013 The American Society of Clinical Oncology (ASCO) has announced important updates to its 2009 Breast Cancer Risk Reduction Guidelines. Nananda Col, M.D., M.P.H., professor of medicine at the University of New England's College of Osteopathic Medicine and faculty member in the Center for Excellence in the Neurosciences, is a member of the ASCO panel that...

2013-04-25 19:46:09

Drinking coffee could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen, a study at Lund University in Sweden has found. Patients who took the pill, along with two or more cups of coffee daily, reported less than half the rate of cancer recurrence, compared with their non-coffee drinking, Tamoxifen-taking counterparts. The team followed over 600 breast cancer patients from southern Sweden for an average of five years. Approximately 300 took...

2011-04-22 00:00:29

Recent research indicates medications such as Tamoxifen or Raloxifene considerably reduce the risk of developing breast cancer in post-menopausal women. MapleLeafMeds is a reputable source for quality drugs like Tamoxifen that doctors believe may slash the risk of breast cancer by up to 43%. Vancouver, BC (PRWEB) April 21, 2011 A recent article in the Lancet Oncology by a panel of cancer experts concluded that women in the higher risk categories for breast cancer could benefit from drugs...

2011-04-06 15:55:28

Breast cancer is the second most common cancer among women, with more than 200,000 women diagnosed each year. Being exposed to estrogen over a long period of time is one factor that can increase a woman's risk of developing the disease. One way a woman can combat this risk factor is by taking the breast cancer drug tamoxifen, which interferes with the activity of estrogen. Now, researchers at Fox Chase Cancer Center have found that omega-3 fatty acids"”abundant in fish"”could be a...

2010-05-10 08:53:19

A study by researchers from the Georgetown Lombardi Comprehensive Cancer Center at Georgetown University Medical Center (GUMC) identifies a potential new combination therapy to "rescue" treatment sensitivity to fulvestrant in estrogen receptor positive breast cancers. The findings are published May 15, 2010 as the cover story of Molecular Cancer Therapeutics. Fulvestrant is a common second-line therapy for women whose cancer progresses following anti-estrogen therapy. In this paper, Lombardi...

2010-04-21 13:22:54

Washington, DC -- For women with hormone receptor-positive breast cancers, treatment after initial surgery is straightforward: a daily dose of an anti-hormone drug will block the tumor from fuel needed for growth, and keep the breast cancer at bay. The treatments work like gangbusters at first, but after time, many tumors become resistant to therapy. With no other treatment options, the cancer grows again and eventually spreads. Teams of scientists from Georgetown Lombardi Comprehensive...

2010-03-04 23:00:00

SEATTLE, March 5 /PRNewswire/ -- Women who take some types of bone-building drugs used to prevent and treat osteoporosis may be at lower risk of breast cancer, according to a study by U.S. researchers published today in the British Journal of Cancer. The study found that women who used bisphosphonate drugs, such as Fosamax, Boniva and Zomita, for more than two years had a nearly 40 percent reduction in risk as compared to those who did not, according to lead author Polly Newcomb, Ph.D.,...

2009-10-20 07:00:00

EMERYVILLE, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Bionovo Inc. (Nasdaq: BNVI) announced today the publication of results from its study on the inhibitory effect of tamoxifen on estrogen receptor beta (ERb) gene regulation. The results of the study, which will be published in Molecular and Cellular Endocrinology, demonstrate that tamoxifen inhibits the beneficial effects of ERb in the prevention of breast cancer cell proliferation. "Tamoxifen has been successfully used to treat...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related